Director Jack E. Stover resigns from PharmaCyte Biotech board effective Nov 1, 2022

PharmaCyte Biotech, Inc.

Jack E. Stover resigned from the board of directors effective November 1, 2022.
Resignation was not due to any disagreement with the company.
No replacement for Mr. Stover was announced in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jack E. Stover

Director

PMCB · PharmaCyte Biotech, Inc.

Effective: 2022-11-01
Filed: November 7, 2022, 6:59 PM ET

On November 1, 2022, Jack E. Stover notified PharmaCyte Biotech, Inc. (the “Company”) of his decision to resign from the board of directors of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jack E. Stover resigned as Director at PharmaCyte Biotech, Inc..

Action: resigned
Role: Director

Exact text from the filing

On November 1, 2022, Jack E. Stover notified PharmaCyte Biotech, Inc. (the “Company”) of his decision to resign from the board of directors of the Company, effective immediately.

View on SEC.gov

PharmaCyte Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-22-007359

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.